Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180,895 | 149,218 | 151,262 | 306,580 | 75,179 |
| Marketable Securities | 899,636 | 866,992 | 853,368 | 760,293 | 621,512 |
| Receivables | 8,298 | 8,130 | 9,403 | 10,107 | 39,937 |
| TOTAL | $1,105,388 | $1,041,793 | $1,029,150 | $1,090,186 | $746,367 |
| Non-Current Assets | |||||
| PPE Net | 27,812 | 26,316 | 25,169 | 21,166 | 21,740 |
| Investments And Advances | 251,839 | 358,629 | 456,798 | 483,771 | 279,821 |
| Other Non-Current Assets | 1,471 | 9,406 | 19,654 | 33,667 | 31,667 |
| TOTAL | $281,122 | $394,351 | $501,621 | $538,604 | $333,228 |
| Total Assets | $1,386,510 | $1,436,144 | $1,530,771 | $1,628,790 | $1,079,595 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,787 | 14,272 | 15,715 | 15,486 | 15,111 |
| Accrued Expenses | 28,798 | 18,444 | 17,758 | 16,431 | 23,680 |
| TOTAL | $62,099 | $57,112 | $66,598 | $80,693 | $95,334 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,514 | 14,990 | 13,471 | 15,109 | 24,876 |
| Other Non-Current Liabilities | 1,301 | 0 | 0 | 0 | 0 |
| TOTAL | $59,697 | $57,428 | $55,569 | $51,587 | $47,994 |
| Total Liabilities | $121,796 | $114,540 | $122,167 | $132,280 | $143,328 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,139 | 84,736 | 84,615 | 84,283 | 83,760 |
| Common Shares | 851 | 847 | 845 | 842 | 772 |
| Retained earnings | -1,246,703 | -1,155,982 | -1,079,190 | -1,007,407 | -956,630 |
| Other shareholders' equity | 4,369 | -7,219 | 18,762 | 52,385 | 48,763 |
| TOTAL | $1,264,714 | $1,321,604 | $1,408,604 | $1,496,510 | $936,267 |
| Total Liabilities And Equity | $1,386,510 | $1,436,144 | $1,530,771 | $1,628,790 | $1,079,595 |